Iclusig PMS in CML or Ph+ALL Patients

Clinical trial NCT03709017 · UNKNOWN

Trial details

NCT number: NCT03709017
Sponsor: Korea Otsuka Pharmaceutical Co., Ltd.
Status: UNKNOWN
Study type: OBSERVATIONAL

Chronic Myeloid Leukemia Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Start date: 2018-08-07
Primary completion: 2022-11-29
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.